H-RAHYNI^VTF-OH

Ref. 3D-PP47569

Informations sur le produit

• Nom: H-RAHYNI^VTF-OH

Description

Peptide H-RAHYNI^VTF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RAHYNI^VTF-OH include the following: A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity YC Song , HY Cheng, CH Leng, SK Chiang - Journal of controlled , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365913008766 Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16 V Khammanivong, XS Liu , WJ Liu - Immunology and cell , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1440-1711.2003.01130.x Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen Content TR Cooney , K Farrand, SL Draper - Bioconjugate , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.3c00106 Functional memory CD8+ T cells can be generated in vivo without evident T help MR Andrews, T Peters, V Khammanivong, GR Leggatt - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X04005754 Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope MPM Vierboom , MCW Feltkamp , A Neisig - Journal of , 1998 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/abstract/1998/11000/peptide_vaccination_with_an_anchor_replaced_ctl.1.aspx Fine Characterization of the HPVI6 E7 49-57 Tumor Protective Cytotoxic T Cell Epitope"Rahynivtf" MCW Feltkamp , MPM Vierboom , J ter Schegget - Immunology of human , 1994 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4615-2449-6_43 Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells MCW Feltkamp , HL Smits - European journal of , 1993 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830230929 Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors MCW Feltkamp , GR Vreugdenhil - European journal of , 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830250935 Self-assembling peptide epitopes as novel platform for anticancer vaccination M Rad-Malekshahi , MF Fransen - Molecular , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b01003 Incorporation of the tat cell-penetrating peptide into nanofibers improves the respective antitumor immune response M Mohammadi , P Dehghani - Journal of cellular , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcp.29946 carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide. M Indrova, J Bubenik, J Simova - International , 2001 - spandidos-publications.comhttps://www.spandidos-publications.com/ijmm/7/1/97 Cytotoxic T lymphocytes raised against a subdominanl epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors JI Schegget, CJM Melief, WM Kast - peptides - academia.eduhttps://www.academia.edu/download/66823771/752_102.pdf HPV 16-Derived Synthetic Peptides with Ability to Upregulate MHC Class I Expression on RMA-S or T2 Cells, as Detected by Enzyme Immunoassay J Dillner - Immunology of Human Papillomaviruses, 1994 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4615-2449-6_32 Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein E Sadovnikova, X Zhu, SM Collins, J Zhou - International , 1994 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/6/2/289/666292 Dissolving of HPV-derived E749-57 peptide for immunization purposes D Pokorna - Collection of Czechoslovak Chemical , 2015 - cccc.uochb.cas.czhttp://cccc.uochb.cas.cz/symposium_series/11/107/pdf/

• Marque: Biosynth